Harmony Reynolds, MD
Enriched profileJoel E. and Joan L. Smilow Professor of Cardiology, NYU Grossman School of Medicine · NYU Grossman School of Medicine
Harmony Reynolds is Joel E. and Joan L. Smilow Professor of Cardiology, NYU Grossman School of Medicine at NYU Grossman School of Medicine. OpenAlex indexes 407 publications with 22,620 citations (h-index 64); ClinicalTrials.gov lists 12 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Harmony Reynolds, M.D., is Joel E. and Joan L. Smilow Professor of Cardiology, NYU Grossman School of Medicine. The public record shows 407 publications with 22,620 citations (h-index 64), centered on Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 5 companies, 3 NIH-funded awards (2004–2025).
- Most recent indexed publication: 2026 · Circulation. Population health and outcomes
- Top research focus: Cardiac Imaging and Diagnostics
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 46 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 163.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Sponsor: Duke University
- Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
Sponsor: Jennifer Lewey, MD, MPH
- mHealth-CArdiac REhabilitation for INOCA
Sponsor: NYU Langone Health
Industry payments
Updated 27 Aug 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20252 payments
- Amgen Inc.Program year20251 payment
- HEARTFLOW, INC.Program year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.3%Statin28.5%Rosuvastatin Calcium52%Atorvastatin Calcium48%Part D≥59 patientsCalcium channel blocker14.3%Amlodipine Besylate90%Diltiazem 24hr Er (Cd)10%Part D<11 patientsMetabolism & gastrointestinal
10.4%SGLT2 inhibitor10.4%Jardiance86%Farxiga14%Part D<11 patientsBlood & clotting
7.3%Factor Xa inhibitor6%Eliquis100%Part D≥22 patientsP2Y12 inhibitor1.3%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 2004–2025 per NIH RePORTER. The latest:
- mHealth-CArdiac REhabilitation for INOCA (INOCA-CARE)
New York University School of Medicine
FY2025$576,600R01HL170666 - mHealth-CArdiac REhabilitation for INOCA (INOCA-CARE)
New York University School of Medicine
FY2025$19,445R01HL170666 - mHealth-CArdiac REhabilitation for INOCA (INOCA-CARE)
New York University School of Medicine
FY2024$593,250R01HL170666
Congress activity
Updated 27 Aug 2026
4 congress contributions (2024) across ASCO, ASH per OpenAlex. The most recent:
- Association of elevated pulmonary artery systolic pressure with hematologic progression in myeloproliferative neoplasms.
ASCO Annual Meeting
ASCO2024Co-author - Incidence, Risk Factors, and Prognostic Implications of Heart Failure Hospitalizations Among Patients with Myeloproliferative Neoplasms
ASH Annual Meeting
ASH2024Co-author - Prognostic Implications of Pulmonary Hypertension in Myeloproliferative Neoplasms and Predictors of Hematologic Progression
ASH Annual Meeting
ASH2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Variability in Cardiac Stress Test Interpretation: Agreement Between Enrollment Sites and Core Laboratories in the Global ISCHEMIA Trial.
Circulation. Population health and outcomes
Article2026 - A Web-Based Virtual Environment Behavioral Intervention as Cardiovascular Disease and Metabolic Disease Prevention Education in Persons With HIV: Evaluation of the LEARN Randomized Controlled Trial.
Journal of medical Internet research
Clinical Trial2026 - Residual Angina Following Complete Revascularization in the ISCHEMIA Trial: Frequency, Clinical Characteristics, Health Status, and Cardiovascular Outcomes.
Journal of the American Heart Association
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01Initial Invasive or Conservative Strategy for Stable Coronary DiseaseArticle2,416 citations2020
- 02Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19Article1,115 citations2020
- 03
- 04ESC working group position paper on myocardial infarction with non-obstructive coronary arteriesArticle894 citations2016
- 05ST-Segment Elevation in Patients with Covid-19 — A Case SeriesArticle858 citations2020
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/harmony-reynolds-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/harmony-reynolds-65a2134
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Harmony-Reynolds
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
tctmd.com/videos/quick-takes-harmony-reynolds-on-the-ischemia-trial.6349386941112
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tctmd.com ↗ - X / Twitter
x.com/nyulangone/status/2003571379854077974
- X / Twitter
x.com/nyulangone/status/2021274223142961474
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Editorial & leadership roles
journal and society appointments- Fellow
American College of Cardiology (FACC)
- Fellow
American College of Physicians (FACP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗ - Fellow
American Heart Association (FAHA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aspconline.org ↗
- "Rock Star of Research" award
American Heart Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nychealthandhospitals.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- Guest
WebMD "Health Discovered" podcast, life after a heart attack
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗ - Episode 18
"Sex Differences, Psychosocial Factors, and Angina", AHA Journals podcast (Aha! with JAHA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ahajournals.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jill Buyon, MD
NYU Grossman School of Medicine
Jeffrey Berger, MD
NYU Grossman School of Medicine
Mark Mulligan, MD
NYU Grossman School of Medicine
David Goldfarb, MD
NYU Grossman School of Medicine